Related Experiment Video
Updated: Jul 13, 2025
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.7K
Making it happen: Development of an interprofessional deprescribing education programme
Natalie Kennie-Kaulbach1, Emma Ramsay1, Hannah Gormley1
1College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
Basic & Clinical Pharmacology & Toxicology
|October 11, 2023
Summary
Deprescribing, the reduction of medications, is crucial for patient safety, especially with aging populations and polypharmacy. This study outlines developing an online educational program to improve healthcare provider deprescribing practices.
Area of Science:
- Gerontology
- Pharmacology
- Medical Education
Background:
- Deprescribing involves planned medication reduction to minimize harm and improve patient outcomes.
- Polypharmacy in an aging population increases risks like falls, hospitalizations, and mortality.
- Effective deprescribing requires collaboration among patients, caregivers, and healthcare providers.
Purpose of the Study:
- To describe the development of an online, interprofessional education program for deprescribing.
- To enhance the deprescribing practices of healthcare providers and students.
Main Methods:
- A needs assessment guided program design, development, and delivery.
- A consultative planning process involved stakeholders and patient partners.
- A core team developed program content, including five modules, and planned for evaluation.
Main Results:
- The stepwise and consultative approach informed program outcomes.
- Five distinct educational modules were developed.
- The program aims to enhance deprescribing skills and knowledge.
Conclusions:
- Online education is a viable strategy to improve deprescribing practices.
- A structured, collaborative development process is key to creating effective educational programs.
- Enhancing deprescribing education can mitigate risks associated with polypharmacy.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:25Antidepressant Drugs: Overview
527
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
527
01:15Drug Abuse and Addiction: Pharmacological Phenomena
489
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
489
01:14CNS Depressants: Barbiturates and Benzodiazepines
290
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
290
01:20Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K